China Biologic Products Holdings, Inc. engages in the research, development, manufacture and sale of human plasma-based biopharmaceutical products or plasma products. Its products include plasma and other products. The company was founded in 2002 and is headquartered in Beijing, China.
Company profile
Website
CEO
Joseph Chow
Employees
Location
Fiscal year end
Industry (SIC)
Former names
China Biologic Products, Inc.
SEC CIK
Corporate docs
IRS number
752308816
Latest filings (excl ownership)
CT ORDER
Confidential treatment order
8 Jul 23
CT ORDER
Confidential treatment order
2 May 23
15-12B
Securities registration termination
30 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Apr 21
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Apr 21
SC 13E3/A
Going private transaction (amended)
21 Apr 21
6-K
China Biologic Announces Completion of Going Private Transaction
20 Apr 21
25-NSE
Exchange delisting
20 Apr 21
6-K
China Biologic Reports Financial Results
29 Mar 21
6-K
China Biologic Announces Shareholders’ Approval of Merger Agreement
1 Mar 21
Transcripts
Latest ownership filings
SC 13D/A
Parfield International Ltd
12 May 23
SC 13D/A
Parfield International Ltd
22 Apr 21
SC 13D/A
HILLHOUSE CAPITAL ADVISORS, LTD.
22 Apr 21
SC 13D/A
Centurium Capital Partners 2018, L.P.
22 Apr 21
SC 13D/A
Chow Joseph
22 Apr 21
SC 13D/A
CITIC Capital Holdings Ltd
22 Apr 21
SC 13D/A
Temasek Holdings (Private) Ltd
21 Apr 21
SC 13D
CPEChina Fund III, L.P.
15 Jan 21
SC 13D/A
Parfield International Ltd
15 Jan 21
SC 13D/A
Chow Joseph
8 Jan 21
Institutional ownership, Q4 2022
9.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 442.99 mm |
Total shares | 3.75 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
CPEChina Fund III | 3.75 mm | $442.99 mm |
Centurium Capital Partners 2018 | 10.00 | $1.00 k |